Literature DB >> 15086282

Spinal cord neuropathology in human West Nile virus infection.

Jonathan D Fratkin1, A Arturo Leis, Dobrivoje S Stokic, Sally A Slavinski, Roger W Geiss.   

Abstract

CONTEXT: During the 1999 New York City West Nile virus (WNV) outbreak, 4 patients with profound muscle weakness, attributed to Guillain-Barré syndrome, were autopsied. These cases were the first deaths caused by WNV, a flavivirus, to be reported in the United States. The patients' brains had signs of mild viral encephalitis; spinal cords were not examined. During the 2002 national epidemic, several patients in Mississippi had acute flaccid paralysis. Electrophysiologic studies localized the lesions to the anterior horn cells in the spinal gray matter. Four of 193 infected patients in Mississippi died and were autopsied. All 4 experienced muscular weakness and respiratory failure that required intubation. Postmortem examinations focused on the spinal cord.
OBJECTIVE: To emphasize apparent tropism of WNV for the ventral gray matter of the spinal cord.
DESIGN: Cerebral hemispheres, basal ganglia, diencephalon, brainstem, cerebellum, and spinal cord sections were stained with hematoxylin-eosin and incubated with antibodies to T cells, B cells, and macrophages/microglial cells.
RESULTS: We identified neuronophagia, neuronal disappearance, perivascular chronic inflammation, and microglial proliferation in the ventral horns of the spinal cord, especially in the cervical and lumbar segments. Loss of ganglionic neurons, nodules of Nageotte, and perivascular lymphocyte aggregates were found in dorsal root and sympathetic ganglia. Severity of cellular reaction was proportional to the interval length between patient presentation and death.
CONCLUSION: West Nile virus caused poliomyelitis. Injury to spinal and sympathetic ganglia mirrored the damage to the spinal gray matter. The disappearance of sympathetic neurons could lead to the autonomic instability observed in some WNV patients, including labile vital signs, hypotension, and potentially lethal cardiac arrhythmias.

Entities:  

Mesh:

Year:  2004        PMID: 15086282     DOI: 10.5858/2004-128-533-SCNIHW

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  37 in total

Review 1.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice.

Authors:  Elizabeth A Hunsperger; John T Roehrig
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

3.  Morphological changes in peri-prostatic sympathetic ganglion cells in aging males.

Authors:  Lea Rath-Wolfson; Asaf Shvero; Golan Bubis; Galina Buzaverov; Aliza Zeidman; Edward Ram; Rumelia Koren
Journal:  Mol Clin Oncol       Date:  2017-03-16

4.  PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.

Authors:  Melanie A Samuel; Kevin Whitby; Brian C Keller; Anantha Marri; Winfried Barchet; Bryan R G Williams; Robert H Silverman; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Is initial preservation of deep tendon reflexes in West Nile Virus paralysis a good prognostic sign?

Authors:  Deb Kumar Mojumder; Melina Agosto; Henrik Wilms; Jongyeol Kim
Journal:  Neurol Asia       Date:  2014-03       Impact factor: 0.183

Review 6.  Neurological approaches for investigating West Nile virus disease and its treatment in rodents.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang
Journal:  Antiviral Res       Date:  2013-09-19       Impact factor: 5.970

7.  Critical West Nile Neuroinvasive Disease.

Authors:  Maximiliano A Hawkes; Ivan D Carabenciov; Eelco F M Wijdicks; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

Review 8.  West Nile virus state of the art report of MALWEST Project.

Authors:  Andriani Marka; Alexandros Diamantidis; Anna Papa; George Valiakos; Serafeim C Chaintoutis; Dimitrios Doukas; Persefoni Tserkezou; Alexios Giannakopoulos; Konstantinos Papaspyropoulos; Eleni Patsoula; Evangelos Badieritakis; Agoritsa Baka; Maria Tseroni; Danai Pervanidou; Nikos T Papadopoulos; George Koliopoulos; Dimitrios Tontis; Chrysostomos I Dovas; Charalambos Billinis; Athanassios Tsakris; Jenny Kremastinou; Christos Hadjichristodoulou; Nikolaos Vakalis; Evdokia Vassalou; Spyridoula Zarzani; Athanassios Zounos; Katerina Komata; Georgios Balatsos; Stavroula Beleri; Anastasia Mpimpa; Vasilios Papavasilopoulos; Ioannis Rodis; Grigorios Spanakos; Nikolaos Tegos; Vasiliki Spyrou; Zisis Dalabiras; Periklis Birtsas; Labrini Athanasiou; Maria Papanastassopoulou; Charalambos Ioannou; Christos Athanasiou; Christos Gerofotis; Elpida Papadopoulou; Theodolinta Testa; Ourania Tsakalidou; George Rachiotis; Nikolaos Bitsolas; Zissis Mamouris; Katerina Moutou; Theologia Sarafidou; Konstantinos Stamatis; Konstantina Sarri; Sotirios Tsiodras; Theano Georgakopoulou; Marios Detsis; Maria Mavrouli; Anastasia Stavropoulou; Lida Politi; Georgia Mageira; Varvara Christopoulou; Georgia Diamantopoulou; Nikolaos Spanakis; Georgia Vrioni; Evangelia-Theofano Piperaki; Kornilia Mitsopoulou; Ilias Kioulos; Antonios Michaelakis; Ioannis Stathis; Ioannis Tselentis; Anna Psaroulaki; Maria Keramarou; Dimosthenis Chochlakis; Yeorgios Photis; Maria Konstantinou; Panagiotis Manetos; Stylianos Tsobanoglou; Spyros Mourelatos; Vasilis Antalis; Panagiotis Pergantas; Georgios Eleftheriou
Journal:  Int J Environ Res Public Health       Date:  2013-12-02       Impact factor: 3.390

9.  Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice.

Authors:  E A Hunsperger; J T Roehrig
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

10.  West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang; Jeffery O Hall; Ramona T Skirpstunas; Aaron L Olsen; Jeffrey L Nordstrom; Scott Koenig; Syd Johnson; Michael S Diamond
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.